Skip to Content

Jadenu Approval History

FDA Approved: Yes (First approved March 30, 2015)
Brand name: Jadenu
Generic name: deferasirox
Dosage form: Tablets
Company: Novartis Pharmaceuticals Corporation
Treatment for: Iron Overload

Jadenu (deferasirox) is a tablet formulation of Exjade, an iron chelator indicated for the treatment of chronic iron overload due to blood transfusions in patients 2 years of age and older.

Development History and FDA Approval Process for Jadenu

DateArticle
Mar 30, 2015Approval FDA Approves Jadenu (deferasirox) Tablets for Chronic Iron Overload

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide